EUVIMEDEUVIMED entdecken
Historischer BeitragEditorialOpen Access

Historical and political context for Philip Morris International’s continuing medical education courses on harm reduction

Pamela M Ling iD, Stanton A Glantz iD

Tobacco Control · 2026

DOI: 10.1136/tc-2024-059015 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Tobacco Control, 2026. Verfasst von Pamela M Ling und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tobacco Control Research and Education, University of California San Francisco, San Francisco, California, USA Pamela.Ling@ucsf.edu. Hauptthemen laut MEDLINE: Harm Reduction, Tobacco Industry, Education, Medical, Continuing, Politics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2024, Philip Morris International’s (PMI) website stated they support ‘independent’ continuing medical education courses on harm reduction for medical and other healthcare professionals. These courses mirrored industry marketing and political strategies by presenting smokeless tobacco products and e-cigarettes as alternatives to smoking, sometimes without mentioning tobacco cessation. The enactment of the US Family Smoking and Tobacco Control Act gave the US Food and Drug Agency jurisdiction over tobacco products and included the industry’s ‘continuum of risk’ frame, and emboldened tobacco companies to make harm reduction claims about these products, which they had previously avoided for fear of triggering restrictive regulation of cigarettes. Opposition from the medical and public health community in the USA and beyond led one large company that partnered with PMI to offer the US courses to withdraw. The Foundation for a Smoke-Free World (renamed Global Action to End Smoking in 2024) created by PMI also funded a non-profit to develop continuing medical education on harm reduction. US accrediting bodies for healthcare education do not have policies against certifying tobacco-sponsored courses, and there needs to be ongoing vigilance against such efforts around the world as well as efforts to secure policies at accrediting organisations to not accredit such industry efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Harm ReductionTobacco IndustryEducation, Medical, ContinuingPoliticsHumansUnited StatesHistory, 21st CenturyHistory, 20th CenturyElectronic Nicotine Delivery SystemsTobacco Products

Stichwörter der Autor:innen

Harm ReductionTobacco industryTobacco industry documents

Autor:innen und Institutionen

  • Center for Tobacco Control Research and Education, University of California San Francisco, San Francisco, California, USA Pamela.Ling@ucsf.edu.
  • Retired, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Pamela M Ling, Stanton A Glantz

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Ling, P. M., & Glantz, S. A. (2026). Historical and political context for Philip Morris International’s continuing medical education courses on harm reduction. Tobacco Control. https://doi.org/10.1136/tc-2024-059015

Vancouver

Ling PM, Glantz SA. Historical and political context for Philip Morris International’s continuing medical education courses on harm reduction. Tobacco Control. 2026. doi:10.1136/tc-2024-059015

BibTeX
@article{Ling2026,
  author = {Ling, Pamela M and Glantz, Stanton A},
  title = {Historical and political context for Philip Morris International’s continuing medical education courses on harm reduction},
  journal = {Tobacco Control},
  year = {2026},
  doi = {10.1136/tc-2024-059015}
}
Kostenlos starten →